Regional Analysis
- North America: The U.S. leads with widespread screening programs and supplemental ultrasound recommendations, while Canada focuses on women’s health initiatives.
- Europe: Germany, France, and the UK drive demand due to robust healthcare systems and aging demographics.
- Asia Pacific: China and India see growth from rising cancer awareness, while Japan emphasizes advanced diagnostics.
- Rest of the World: Brazil expands screening access, and the Middle East invests in cutting-edge medical technologies.
Application Analysis
- Hospitals: Expected growth of 9.5%-13.2%, driven by comprehensive diagnostics. Trends focus on integrated imaging systems.
- Diagnostic Imaging Laboratories: Projected growth of 10.0%-13.8%, linked to specialized screening. Developments emphasize high-throughput solutions.
- Others: Anticipated growth of 9.2%-12.9%, covering niche uses. Advances prioritize patient comfort.
Type Analysis
- Automated Breast Volume Scanner: Expected growth of 9.7%-13.4%, valued for 3D imaging. Trends highlight volumetric data accuracy.
- Automated Breast Ultrasound (ABUS): Projected growth of 9.9%-13.6%, key for dense tissue detection. Advances focus on AI enhancements.
Key Market Players
Leading companies include GE HealthCare, innovating with MyBreastAI; Philips, advancing with EPIQ systems; Siemens Healthcare, enhancing imaging solutions; CANON MEDICAL SYSTEMS CORPORATION, focusing on ultrasound tech; TELEMED Medical Systems, offering diagnostic tools; Hologic, specializing in breast health; SuperSonic Imagine, developing imaging systems; Lunit, integrating AI diagnostics; and Delphinus Medical Technologies, launching SoftVue.Porter's Five Forces Analysis
- Threat of New Entrants: Moderate, due to high technological and regulatory barriers, though innovative startups can disrupt niches.
- Threat of Substitutes: Low, as ABUS uniquely enhances detection in dense breasts with no direct alternatives.
- Bargaining Power of Buyers: Moderate, with facilities seeking advanced yet cost-effective tools, though specialized needs limit options.
- Bargaining Power of Suppliers: Low, with multiple component suppliers available.
- Competitive Rivalry: High, with firms competing on AI integration, imaging quality, and screening efficiency.
Market Opportunities and Challenges
Opportunities
- Breast cancer’s 2.3 million annual cases and dense breast prevalence (40%-50%) drive demand.
- Aging populations (2.1 billion over 60 by 2050) and obesity increase risks, while awareness campaigns and government funding boost screening.
- AI and 3D imaging improve outcomes, and radiation-free preferences enhance adoption.
Challenges
- High costs of ABUS systems limit penetration in low-income regions.
- Regulatory delays for AI-integrated devices slow entry.
- Limited radiologists in rural areas restrict growth.
Market News:
- In July 2024, Delphinus Medical Technologies, Inc. installed SoftVue breast ultrasound tomography at West Jefferson Medical Center in Louisiana.
- In May 2022, iSono Health received US FDA clearance for the ATUSA System, a portable breast imaging system.
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- GE HealthCare
- Philips
- Siemens Healthcare
- CANON MEDICAL SYSTEMS CORPORATION
- TELEMED Medical Systems
- Hologic
- SuperSonic Imagine
- Lunit
- Delphinus Medical Technologies


 
   
     
   
   
    